As a descendant of an Indigenous Amazonian tribe, Maria Astolfi was concerned about research she conducted as a graduate ...

It will build a Wilmington, Delaware facility dedicated to making its cancer drug, Keytruda, for U.S. patients.

Animal-free egg protein intended to alleviate egg shortages will be coming from a biotech firm building its first plant in ...

Following President Trump's executive order, the Indian pharmaceutical industry anticipates a surge in unannounced ...

The drug maker on Tuesday announced a new 470,000-square-foot facility in Wilmington, Delaware, where it will make Keytruda, the company's immunotherapy treatment for different cancers. The plant ...

Amgen on Friday announced a $900 million expansion of its Ohio biotech manufacturing facility, becoming the latest in a ...

An age-old question about which came first, the chicken or the egg, won't matter for a biotech startup that aims ... has plans for a 130,000-square-foot plant in Jefferson County that would ...

The biotechnology company announced in December plans to invest $1 billion to build a second drug substance manufacturing plant in Holly Springs, North Carolina. Amgen also has manufacturing ...